85
Participants
Start Date
October 31, 2006
Primary Completion Date
July 31, 2012
Study Completion Date
April 30, 2014
Sorafenib
Paclitaxel
Paclitaxel
Carboplatin
Carboplatin
Center for Cancer and Blood Disorders, Bethesda
National Capital Clinical Research Consortium, Bethesda
Peninsula Cancer Center, Newport News
South Carolina Oncology Associates, PA, Columbia
Medical College of Georgia Cancer Specialists, Augusta
Holy Cross Hospital, Fort Lauderdale
Gulfcoast Oncology Associates, St. Petersburg
Florida Cancer Specialists, Fort Myers
Tennessee Oncology, PLLC, Nashville
Tennessee Valley Clinical Research, Chattanooga
Family Cancer Center, Collierville
Oncology Hematology Care, Cincinnati
Providence Medical Group, Terre Haute
St. Joseph Mercy Hospital, Ann Arbor
Grand Rapids Clinical Oncology Program, Grand Rapids
Northeast Arkansas Clinic, Jonesboro
University of Oklahoma, Oklahoma City
Collaborators (1)
Bayer
INDUSTRY
SCRI Development Innovations, LLC
OTHER